Belite Bio, Inc (BLTE) KPIs and segments

BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 5/30

$169.96+14.02 (+8.99%)

Close on Nov 12, 2026Market cap $6.69BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Belite Bio's business

Coming soon

This tab will track the numbers specific to Belite Bio's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?